Izun Pharmaceuticals Overview
- Year Founded
-
2000
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
2ndary - Private
Izun Pharmaceuticals General Information
Description
Operator of a biopharmaceutical company intended to identify novel treatment candidates and manufacture pharmaceutical products. The company develops non-steroidal topical oral anti-inflammatory therapies for periodontal treatments and provides oncology-support therapies, enabling healthcare professionals to have more effective cancer therapy, as well as improve the quality of life for cancer patients.
Contact Information
Website
www.izunpharma.comCorporate Office
- One Rockefeller Plaza
- 11th Floor
- New York, NY 10020
- United States
Corporate Office
- One Rockefeller Plaza
- 11th Floor
- New York, NY 10020
- United States
Izun Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Secondary Transaction - Private | 01-Oct-2022 | 00.00 | Completed | Clinical Trials - Phase 4 | ||
2. Later Stage VC | 13-Nov-2014 | 00.000 | 00.00 | Completed | Clinical Trials - Phase 4 | |
1. Seed Round | 19-Jun-2012 | $4.08M | $4.08M | Completed | Clinical Trials - Phase 4 |
Izun Pharmaceuticals Comparisons
Industry
Financing
Details
Izun Pharmaceuticals Competitors (62)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
CNBX Pharmaceuticals | Corporation | Bethesda, MD | 0 | 000.00 | 000000000 | 000.00 |
ACADIA Pharmaceuticals | Formerly VC-backed | San Diego, CA | 000 | 00000 | 000000&0 | |
AB Science | Formerly Accelerator/Incubator backed | Paris, France | 00 | 00000 | 000000000 | 00000 |
Akelos | Venture Capital-Backed | New York, NY | 0 | 00.000 | 000000000 | 00.000 |
Renova Therapeutics | Venture Capital-Backed | Carlsbad, CA | 000.00 | 0000000000 0 | 000.00 |
Izun Pharmaceuticals Patents
Izun Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4236978-A1 | Treatment of oral mucositis | Pending | 28-Oct-2020 | 000000000 | |
US-20230390350-A1 | Treatment of oral mucositis | Pending | 28-Oct-2020 | 000000000 | |
AU-2020339841-A1 | Protein based cannabis compositions | Pending | 29-Aug-2019 | 0000000000 | |
EP-4021440-A1 | Protein based cannabis compositions | Pending | 29-Aug-2019 | 0000000000 | |
EP-4021440-A4 | Protein based cannabis compositions | Pending | 29-Aug-2019 | A23J3/14 | 0 |
Izun Pharmaceuticals Executive Team (6)
Name | Title | Board Seat |
---|---|---|
Jonathan Kalman | Chief Executive Officer & Board Member | |
Les Kraus | Co-Chief Financial Officer and Chief Operating Officer | |
William Levine | Founder & Chief Scientific Officer | |
David Birmann | Co-Founder & Director | |
Amy Rosenbluh | Director of Production and Laboratory Director & Board Member |
Izun Pharmaceuticals Board Members (11)
Name | Representing | Role | Since |
---|---|---|---|
Alan Adler | Self | Board Member | 000 0000 |
Amy Rosenbluh | Izun Pharmaceuticals | Director of Production and Laboratory Director & Board Member | 000 0000 |
Gabriel Nussbaum | Self | Board Member | 000 0000 |
Jonathan Kalman | Izun Pharmaceuticals | Chief Executive Officer & Board Member | 000 0000 |
Oscar Schafer | Self | Board Member | 000 0000 |
Izun Pharmaceuticals Signals
Izun Pharmaceuticals FAQs
-
When was Izun Pharmaceuticals founded?
Izun Pharmaceuticals was founded in 2000.
-
Who is the founder of Izun Pharmaceuticals?
William Levine and David Birmann are the founders of Izun Pharmaceuticals.
-
Who is the CEO of Izun Pharmaceuticals?
Jonathan Kalman is the CEO of Izun Pharmaceuticals.
-
Where is Izun Pharmaceuticals headquartered?
Izun Pharmaceuticals is headquartered in New York, NY.
-
What is the size of Izun Pharmaceuticals?
Izun Pharmaceuticals has 12 total employees.
-
What industry is Izun Pharmaceuticals in?
Izun Pharmaceuticals’s primary industry is Biotechnology.
-
Is Izun Pharmaceuticals a private or public company?
Izun Pharmaceuticals is a Private company.
-
What is Izun Pharmaceuticals’s current revenue?
The current revenue for Izun Pharmaceuticals is 000000.
-
How much funding has Izun Pharmaceuticals raised over time?
Izun Pharmaceuticals has raised $5.2M.
-
Who are Izun Pharmaceuticals’s competitors?
CNBX Pharmaceuticals, ACADIA Pharmaceuticals, AB Science, Akelos, and Renova Therapeutics are some of the 62 competitors of Izun Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »